Your browser doesn't support javascript.
loading
Leukemia core transcriptional circuitry is a sparsely interconnected hierarchy stabilized by incoherent feed-forward loops.
Harada, Taku; Kalfon, Jérémie; Perez, Monika W; Eagle, Kenneth; Braes, Flora Dievenich; Batley, Rashad; Heshmati, Yaser; Ferrucio, Juliana Xavier; Ewers, Jazmin; Mehta, Stuti; Kossenkov, Andrew; Ellegast, Jana M; Bowker, Allyson; Wickramasinghe, Jayamanna; Nabet, Behnam; Paralkar, Vikram R; Dharia, Neekesh V; Stegmaier, Kimberly; Orkin, Stuart H; Pimkin, Maxim.
Afiliación
  • Harada T; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Kalfon J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, 02142, USA.
  • Perez MW; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Eagle K; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Braes FD; Ken Eagle Consulting, Houston, TX, 77494, USA.
  • Batley R; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Heshmati Y; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Ferrucio JX; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Ewers J; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Mehta S; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Kossenkov A; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Ellegast JM; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Bowker A; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Wickramasinghe J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, 02142, USA.
  • Nabet B; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Paralkar VR; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Dharia NV; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Stegmaier K; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Orkin SH; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
  • Pimkin M; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, 02142, USA.
bioRxiv ; 2023 Mar 15.
Article en En | MEDLINE | ID: mdl-36993171
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos